Follow-ons completed by biopharma companies, including: Adaptimmune, Albireo, Alector, Apellis, Applied, Aptinyx, Autolus, Biohaven, Blueprint Medicines, Catabasis, Concert, DBV, Denali, Heat Biologics, Hutchison China Meditech, Immunogen, Intelgenx, Intra-Cellular, Matinas, Mirati, Mirum, Nanoviricides, Osmotica, Trillium, Xenon, Zai Lab, Zymeworks.